Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Xyzal now available in US for allergy treatment
The companies say Xyzal is an oral antihistamine that has been shown to provide powerful allergy symptom relief. It is approved for use in adults and children six
The companies say Xyzal is an oral antihistamine that has been shown to provide powerful allergy symptom relief. It is approved for use in adults and children six
The clinical trial was a multicenter, double-blind, placebo-controlled trial including 426 patients with major depression. According to the company, Lu AA21004 showed highly significant improvements on the primary
The approval of the supplemental biologics license application is based on prolonged overall survival from a large, randomized, multicenter, Phase III trial comparing Erbitux plus best supportive care
The drug, CVBT-141B, is formulated with human fibroblast growth factor-1 (FGF-1) and was applied topically in eight subjects at a single site. CardioVascular BioTherapeutics said that the formulation
This designation is based on a recommendation from the Committee for Orphan Medicinal Products. Dr Paul Laikind, president and CEO, said: “Patients with primary liver cancer often die
The decision means a delay to a milestone payment Vernalis is due from US partner Endo Pharmaceuticals. The $40 million payment triggered by an approval would have gone
In the study, patients with moderate to severe disease who achieved 75% improvement in psoriasis signs and symptoms at 12 weeks stopped receiving investigational anti-IL-12/23 antibody ABT-874. At
Emory University scientists found that the compound, known as gambogic amide, behaves much like nerve growth factor (NGF), a molecule found in the brain. NGF binds to TrkA,
The trial with SNT-MC17, named IONIA (idebenone effects on neurological ICARS assessments), is a double-blind, randomized, placebo-controlled study of six months duration investigating the efficacy of two doses
<p>The Carbon Disclosure Project (CDP) report is a survey of the responses of Financial Times 500 corporations on the issue of climate change. In the report, Unilever was